CIK: 0001958125 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $540,930 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 57,376 | $43,778 | 8.1% | $793.52 | -6.5% | COM | 532457108 |
| ABBV | ABBVIE INC | 154,834 | $35,850 | 6.6% | $201.95 | 0.0% | COM | 00287Y109 |
| BBIO | BRIDGEBIO PHARMA INC | 622,729 | $32,345 | 6.0% | $26.37 | +85.0% | COM | 10806X102 |
| ISRG | INTUITIVE SURGICAL INC | 71,343 | $31,907 | 5.9% | $513.00 | -6.5% | COM NEW | 46120E602 |
| ASND | ASCENDIS PHARMA A/S | 144,954 | $28,818 | 5.3% | $137.67 | — | SPONSORED ADR | 04351P101 |
| SLNO | SOLENO THERAPEUTICS INC | 418,245 | $28,273 | 5.2% | $64.77 | +14.5% | COM | 834203309 |
| DNTH | DIANTHUS THERAPEUTICS INC | 667,615 | $26,271 | 4.9% | $25.71 | -0.6% | COM | 252828108 |
| BSX | BOSTON SCIENTIFIC CORP | 262,972 | $25,674 | 4.7% | $101.49 | +2.0% | COM | 101137107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,614,717 | $24,842 | 4.6% | $13.56 | -3.5% | COM | 87164F105 |
| CYTK | CYTOKINETICS INC | 451,581 | $24,819 | 4.6% | $50.21 | -18.0% | COM NEW | 23282W605 |
| NTRA | NATERA INC | 148,369 | $23,883 | 4.4% | $156.65 | +1.0% | COM | 632307104 |
| REGN | REGENERON PHARMACEUTICALS | 35,344 | $19,873 | 3.7% | $564.28 | 0.0% | COM | 75886F107 |
| GPCR | STRUCTURE THERAPEUTICS INC | 651,810 | $18,251 | 3.4% | $25.23 | — | SPONSORED ADS | 86366E106 |
| QURE | UNIQURE NV | 282,940 | $16,515 | 3.1% | $8.63 | +110.3% | SHS | N90064101 |
| IRON | DISC MEDICINE INC | 216,527 | $14,308 | 2.6% | $57.71 | +3.1% | COM | 254604101 |
| ABVX | ABIVAX SA | 162,141 | $13,766 | 2.5% | $84.90 | — | SPONSORED ADS | 00370M103 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 287,090 | $13,720 | 2.5% | $40.27 | 0.0% | COM | 868459108 |
| EXAS | EXACT SCIENCES CORP | 248,987 | $13,622 | 2.5% | $49.96 | 0.0% | COM | 30063P105 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,128,521 | $13,283 | 2.5% | $7.47 | +38.2% | COM | 71722W107 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 884,890 | $13,238 | 2.4% | $8.47 | +43.8% | COM | 00650F109 |
| RNAM | AVIDITY BIOSCIENCES INC | 263,256 | $11,470 | 2.1% | $40.43 | 0.0% | COM | 05370A108 |
| ADMA | ADMA BIOLOGICS INC | 684,508 | $10,035 | 1.9% | $19.85 | -13.6% | COM | 000899104 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 291,262 | $8,761 | 1.6% | $34.43 | -12.9% | COM | 90400D108 |
| GUTS | FRACTYL HEALTH INC | 5,214,236 | $8,291 | 1.5% | $1.34 | -3.2% | COM | 35168W103 |
| GRAL | GRAIL INC | 137,928 | $8,156 | 1.5% | $38.21 | 0.0% | COM | 384747101 |
| TARA | PROTARA THERAPEUTICS INC | 1,500,793 | $6,528 | 1.2% | $3.30 | -2.0% | COM STK | 74365U107 |
| SEPN | SEPTERNA INC | 294,360 | $5,537 | 1.0% | $23.65 | -44.5% | COM | 81734D104 |
| — | CIDARA THERAPEUTICS INC | 53,333 | $5,107 | 0.9% | $95.76 | — | COM NEW | 171757206 |
| KYTX | KYVERNA THERAPEUTICS INC | 586,909 | $3,521 | 0.7% | $4.79 | -16.6% | COM | 501976104 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,061,132 | $2,748 | 0.5% | $2.92 | 0.0% | COM | 28617K101 |
| OM | OUTSET MED INC | 118,279 | $1,670 | 0.3% | $11.92 | +30.8% | COM NEW | 690145206 |
| MGX | METAGENOMI INC | 528,993 | $1,254 | 0.2% | $2.41 | -15.9% | COM | 59102M104 |
| — | ATAI LIFE SCIENCES NV | 196,858 | $1,041 | 0.2% | $1.33 | — | SHS | N0731H103 |
| HYPR | HYPERFINE INC | 684,541 | $993 | 0.2% | $0.96 | +21.4% | COM CL A | 44916K106 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 133,131 | $955 | 0.2% | $42.39 | +22.9% | CLASS A ORD | 61559X104 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 142,984 | $935 | 0.2% | $8.54 | -37.0% | COM NEW | 48576U205 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 12,010 | $753 | 0.1% | $44.59 | 0.0% | COM | 697947109 |
| SNSE | SENSEI BIOTHERAPEUTICS INC | 14,718 | $139 | 0.0% | $7.18 | +15.6% | COM NEW | 81728A207 |